Reliance
Life to try stem cells in cardiology So the next breakthrough in cardiac therapy could be from
India and the global patents would go to an Indian company,
if Reliance Life Sciences succeeds in its ambitious stem cell
research programme.
Anna
Univ. files for 5 leads in US The Anna University in Chennai has filed for five US patents
for molecules isolated from medicinal plants for its anti-cancer,
anti-diabetes and immuno modulatory properties.
Leave
generics to market forces: industry, trade ask NPPA The Pharmaceutical industry and trade community do not
want NPPA to intervene in the issue of generic pricing and
are against any move by the apex pharmaceutical pricing body
that would result in ceiling of trade margins.
Diphenoxylate
unsafe, yet promoted Pharmaceutical companies many a time indulge in
unethical promotion and marketing of potentially hazardous
drug in spite of the awareness of danger.
Era
of relationship marketing THERE was a time in pharma marketing when quality
alone was an important factor. If a company offered
quality products it was sure to gain an adequate share
in the prescription market.
Promotion,
price & prohibition The interest shown by the National Pharmaceutical
Pricing Authority (NPPA) to regulate the sale of generic
products by fixing retail margins is untimely, Microbial
Armageddon: Vancomycin v/s MRSA and VRE Vancomycin is a clinically indispensable antibiotic
and is the drug of last resort for treatment of multidrug-resistant
infections. Bacterial resistance to vancomycin is now
emerging.
